Sophisticated benefits advisor navigates the complex wellness marketplace to bring clients a vetted preventive screening platform FORT WORTH, Texas, Jan. 27, 2026Sophisticated benefits advisor navigates the complex wellness marketplace to bring clients a vetted preventive screening platform FORT WORTH, Texas, Jan. 27, 2026

Higginbotham Expands Prevention with New Wellness Option: Function Health

2026/01/28 00:31
4 min read

Sophisticated benefits advisor navigates the complex wellness marketplace to bring clients a vetted preventive screening platform

FORT WORTH, Texas, Jan. 27, 2026 /PRNewswire/ — Higginbotham, a broad-based, employee-owned insurance and financial services firm headquartered in Texas and a trusted leader in employee benefits consulting, has expanded its well-being service offerings with the addition of Function Health. This new preventive screening platform strengthens Higginbotham’s portfolio of population health solutions, giving clients another strategic option to help them build comprehensive health and benefits programs for their employees.

Higginbotham adds Function Health, expanding preventive care with a vetted wellness screening option.

The addition strengthens Higginbotham’s role as a trusted advisor in an increasingly complex benefits marketplace. Higginbotham focuses on practical innovation over trends, seeking to offer solutions that are implementable, measurable and work effectively alongside core medical plans.

“This isn’t wellness as a perk; it’s prevention as a core component of total rewards and workforce strategy,” said Katelynne Callender, Director, Population Health Management at Higginbotham. “Employers are moving toward proactive prevention. Our role is to understand the evolving landscape of solutions, assess what truly fits our clients’ needs, and help them adopt those tools in a thoughtful, data-informed way.”

Callender added, “We’re continuously looking to expand the value we deliver to clients. Function represents a strong addition to our prevention strategy that supports health literacy and earlier intervention, with the goal of mitigating high-cost claims, and driving more sustainable, long-term population health outcomes.”

Function Health’s platform offers twice-yearly comprehensive testing across approximately 100 biomarkers, including cardiovascular health, hormones, nutrients, toxins and metabolic markers. This early detection approach can help identify certain chronic conditions before symptoms appear, which may enable intervention when treatment is most effective.

“Higginbotham’s deep experience in employee benefits and their employer-first advisory approach make them an ideal partner to bring preventive health screening to scale,” said Jonathan Swerdlin, CEO of Function Health. “Their clients represent forward-thinking employers who understand that investing in prevention today reduces healthcare costs and improves workforce productivity tomorrow.”

“Our clients rely on us for solutions that fit their population and goals,” said Callender. “Function Health is one more tool we can now offer.”

As a carrier-agnostic adviser, Higginbotham works with carriers and supplements traditional coverage with specialized solutions like Function Health. This approach helps enable clients to create customized benefits programs to address the full range of employee needs, from core medical coverage to proactive wellness initiatives. The service is currently available to Higginbotham clients and their employees for $334 annually, independent of their carrier selection.

This addition reflects Higginbotham’s ongoing commitment to expanding its advisory capabilities and providing clients with access to innovative solutions across the benefits landscape.

About Higginbotham
Higginbotham is an employee-owned leader in insurance, financial services and employee benefits. Since 1948, the firm has combined national reach with local expertise, ranking as the 18th largest independent insurance brokerage in the U.S., according to The Hales Report in 2025. Higginbotham delivers customized programs supported by its Day Two Services®, designed to ensure that clients receive proactive guidance and support throughout the life of every policy.

Guided by a values-driven culture, the firm is committed to its employees, clients, carrier partners and the communities it serves. Learn more at Higginbotham.com.

About Function
Function is on a mission to empower everyone to live 100 healthy years, and is making lab testing, advanced MRI and CT scans, and longitudinal health data accessible and understandable. Function is developing Medical Intelligence, a continuous learning system designed to help people see, understand, and act on their biology in real time. Unlike the average annual physical, which typically measures roughly 26 biomarkers, Function members receive access to 160+ lab tests spanning heart, hormones, thyroid, liver, kidneys, heavy metals, nutrients, inflammation, cancer signals, and more biannually for $365 per year – $1/day. Through its acquisition of Ezra, Function now offers MRI powered by FDA-cleared AI that takes just 22 minutes and costs $499, making potentially lifesaving advanced scans accessible to more people. The advanced MRI can detect cancers, unruptured aneurysms, endometriosis, signs of stroke, etc., while the CT scan can identify lung cancer, plaque in the heart, etc. All data is integrated into a single intelligent interface, giving each member a personalized view of their health and enabling powerfully informed decisions. By turning data into action, Function is redefining what it means to take control of your health.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/higginbotham-expands-prevention-with-new-wellness-option-function-health-302670514.html

SOURCE Higginbotham

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

HitPaw API is Integrated by Comfy for Professional Image and Video Enhancement to Global Creators

HitPaw API is Integrated by Comfy for Professional Image and Video Enhancement to Global Creators

SAN FRANCISCO, Feb. 7, 2026 /PRNewswire/ — HitPaw, a leader in AI-powered visual enhancement solutions, announced Comfy, a global content creation platform, is
Share
AI Journal2026/02/08 09:15
Journalist gives brutal review of Melania movie: 'Not a single person in the theater'

Journalist gives brutal review of Melania movie: 'Not a single person in the theater'

A Journalist gave a brutal review of the new Melania documentary, which has been criticized by those who say it won't make back the huge fees spent to make it,
Share
Rawstory2026/02/08 09:08
Facts Vs. Hype: Analyst Examines XRP Supply Shock Theory

Facts Vs. Hype: Analyst Examines XRP Supply Shock Theory

Prominent analyst Cheeky Crypto (203,000 followers on YouTube) set out to verify a fast-spreading claim that XRP’s circulating supply could “vanish overnight,” and his conclusion is more nuanced than the headline suggests: nothing in the ledger disappears, but the amount of XRP that is truly liquid could be far smaller than most dashboards imply—small enough, in his view, to set the stage for an abrupt liquidity squeeze if demand spikes. XRP Supply Shock? The video opens with the host acknowledging his own skepticism—“I woke up to a rumor that XRP supply could vanish overnight. Sounds crazy, right?”—before committing to test the thesis rather than dismiss it. He frames the exercise as an attempt to reconcile a long-standing critique (“XRP’s supply is too large for high prices”) with a rival view taking hold among prominent community voices: that much of the supply counted as “circulating” is effectively unavailable to trade. His first step is a straightforward data check. Pulling public figures, he finds CoinMarketCap showing roughly 59.6 billion XRP as circulating, while XRPScan reports about 64.7 billion. The divergence prompts what becomes the video’s key methodological point: different sources count “circulating” differently. Related Reading: Analyst Sounds Major XRP Warning: Last Chance To Get In As Accumulation Balloons As he explains it, the higher on-ledger number likely includes balances that aggregators exclude or treat as restricted, most notably Ripple’s programmatic escrow. He highlights that Ripple still “holds a chunk of XRP in escrow, about 35.3 billion XRP locked up across multiple wallets, with a nominal schedule of up to 1 billion released per month and unused portions commonly re-escrowed. Those coins exist and are accounted for on-ledger, but “they aren’t actually sitting on exchanges” and are not immediately available to buyers. In his words, “for all intents and purposes, that escrow stash is effectively off of the market.” From there, the analysis moves from headline “circulating supply” to the subtler concept of effective float. Beyond escrow, he argues that large strategic holders—banks, fintechs, or other whales—may sit on material balances without supplying order books. When you strip out escrow and these non-selling stashes, he says, “the effective circulating supply… is actually way smaller than the 59 or even 64 billion figure.” He cites community estimates in the “20 or 30 billion” range for what might be truly liquid at any given moment, while emphasizing that nobody has a precise number. That effective-float framing underpins the crux of his thesis: a potential supply shock if demand accelerates faster than fresh sell-side supply appears. “Price is a dance between supply and demand,” he says; if institutional or sovereign-scale users suddenly need XRP and “the market finds that there isn’t enough XRP readily available,” order books could thin out and prices could “shoot on up, sometimes violently.” His phrase “circulating supply could collapse overnight” is presented not as a claim that tokens are destroyed or removed from the ledger, but as a market-structure scenario in which available inventory to sell dries up quickly because holders won’t part with it. How Could The XRP Supply Shock Happen? On the demand side, he anchors the hypothetical to tokenization. He points to the “very early stages of something huge in finance”—on-chain tokenization of debt, stablecoins, CBDCs and even gold—and argues the XRP Ledger aims to be “the settlement layer” for those assets.He references Ripple CTO David Schwartz’s earlier comments about an XRPL pivot toward tokenized assets and notes that an institutional research shop (Bitwise) has framed XRP as a way to play the tokenization theme. In his construction, if “trillions of dollars in value” begin settling across XRPL rails, working inventories of XRP for bridging, liquidity and settlement could rise sharply, tightening effective float. Related Reading: XRP Bearish Signal: Whales Offload $486 Million In Asset To illustrate, he offers two analogies. First, the “concert tickets” model: you think there are 100,000 tickets (100B supply), but 50,000 are held by the promoter (escrow) and 30,000 by corporate buyers (whales), leaving only 20,000 for the public; if a million people want in, prices explode. Second, a comparison to Bitcoin’s halving: while XRP has no programmatic halving, he proposes that a sudden adoption wave could function like a de facto halving of available supply—“XRP’s version of a halving could actually be the adoption event.” He also updates the narrative context that long dogged XRP. Once derided for “too much supply,” he argues the script has “totally flipped.” He cites the current cycle’s optics—“XRP is sitting above $3 with a market cap north of around $180 billion”—as evidence that raw supply counts did not cap price as tightly as critics claimed, and as a backdrop for why a scarcity narrative is gaining traction. Still, he declines to publish targets or timelines, repeatedly stressing uncertainty and risk. “I’m not a financial adviser… cryptocurrencies are highly volatile,” he reminds viewers, adding that tokenization could take off “on some other platform,” unfold more slowly than enthusiasts expect, or fail to get to “sudden shock” scale. The verdict he offers is deliberately bound. The theory that “XRP supply could vanish overnight” is imprecise on its face; the ledger will not erase coins. But after examining dashboard methodologies, escrow mechanics and the behavior of large holders, he concludes that the effective float could be meaningfully smaller than headline supply figures, and that a fast-developing tokenization use case could, under the right conditions, stress that float. “Overnight is a dramatic way to put it,” he concedes. “The change could actually be very sudden when it comes.” At press time, XRP traded at $3.0198. Featured image created with DALL.E, chart from TradingView.com
Share
NewsBTC2025/09/18 11:00